Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder, The Haul Company
Managing Director, D.E. Shaw and Co., L.P.
Partner at New Enterprise Associates
Join Prescience for lunch to hear from David Kirn, a global leader in the clinical research and development of oncolytic viruses for cancer. Kirn will talk about Jennerex Biotherapeutics, one of the Bay Area’s most promising clinical-stage biotherapeutics companies. Jennerex’s lead product is currently in a Phase 2b clinical trial for hepatocellular carcinoma and Phase 1/2 clinical development for colorectal cancer. Kirn will share insights into the science on which Jennerex is based, tips for founding a successful start-up, and his vision for the future of the life sciences. More information and online registration is here.